chevron_leftBack
I
As of 14 June 2026, IMPACT Therapeutics, Inc. Class H has a market cap of $1.41B USD, ranking #8814 globally and #2321 in China.
It ranks #741 in the Healthcare sector, and #146 in the Biotechnology industry.
Key Stats
Market Cap
$1.41BUSD
11.02B HKD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 6.8% | 33% | 20% | 20% | 20% | 20% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
7630
ISIN: CNE100007LG4
Shares Out.:
Shares Outstanding:
276.165M1
Shares Float:
164.614M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
42.60 HKD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHEK: 2269
|
$17.44B
1K%
136.71B HKD
|
25.3
|
|
SHEK: 1093
|
$12.2B
767%
95.58B HKD
|
22.1
|
|
SHE: 002422
|
$8.0B
469%
54.23B CNY
|
34.4
|
|
|
$7.33B
422%
49.69B CNY
|
-
|
||
SHEK: 1530
|
$7.08B
404%
55.5B HKD
|
5.8
|
|
SHE: 300347
|
$6.72B
378%
45.52B CNY
|
61.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
13K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
11K%
|
19.0
|
|
EBR: ARGX
|
$47.84B
3K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
3K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
3K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
3K%
33.71B CHF
|
37.2
|
chevron_leftBack